News & Insights

News & Insights

News & Insights

September 4, 2023

Articles

New CEO has brought change to AJ Vaccines: There was a distinct lack of communication

Ole Vahlgren has completed his first full financial year as CEO of AJ Vaccines, and it has been a start-up with a focus on strengthening communication both internally and externally. 

Read more

March 24, 2022

News

World Tuberculosis Day 2022

As one of a few BCG vaccine manufacturers in the world, we are pleased to mark World Tuberculosis (TB) Day on March 24 to raise public awareness about the devastating consequences of tuberculosis (TB), and to step up efforts to end TB globally.

Read more

February 1, 2022

Press release

Change of guard at AJ Vaccines A/S

CEO Jesper Helmuth Larsen leaves AJ Vaccines A/S effective 31 January 2022. He will be succeeded by Ole Vahlgren who will assume the responsibility as CEO of AJ Vaccines A/S effective today 1 February 2022. We are pleased to welcome Ole Vahlgren as our new CEO.

Read more

January 16, 2022

News

Celebrating our 5-year anniversary, serving millions of people globally

Today, five years ago, AJ Vaccines emerged as a new life science company, and thus the first steps were taken towards securing a world free of serious diseases. It has been five eventful years where we as a company have worked purposefully and committed to develop innovative vaccines, diagnostics and therapeutic solutions of the highest quality for the world.

Read more